506600 Sigma-AldrichPamidronate, Disodium Salt - CAS 109552-15-0 - Calbiochem
A potent and specific inhibitor of bone resorption that does not cause any significant detrimental effect on bone growth and mineralization at concentrations used.
More>> A potent and specific inhibitor of bone resorption that does not cause any significant detrimental effect on bone growth and mineralization at concentrations used. Less<<Synonyms: 3-Amino-1-hydroxypropylidene-bisphosphonic Acid, 2Na, Pentahydrate
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
109552-15-0 | C₃H₉NO₇P₂·2Na·5H₂O |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
506600-10MG |
|
Plastic ampoule | 10 mg |
|
— |
References | |
---|---|
References | Fromigue, O., et al. 2000. J. Bone Miner. Res. 15, 2211. Fitton, A., and McTravish, D. 1991. Drugs 41, 289. |
Product Information | |
---|---|
CAS number | 109552-15-0 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₃H₉NO₇P₂·2Na·5H₂O |
Chemical formula | C₃H₉NO₇P₂·2Na·5H₂O |
Hygroscopic | Hygroscopic |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Inhibitor of bone resorption |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | SZ6522666 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
506600-10MG | 04055977272482 |
Documentation
Pamidronate, Disodium Salt - CAS 109552-15-0 - Calbiochem SDS
Title |
---|
Pamidronate, Disodium Salt - CAS 109552-15-0 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
506600 |
References
Reference overview |
---|
Fromigue, O., et al. 2000. J. Bone Miner. Res. 15, 2211. Fitton, A., and McTravish, D. 1991. Drugs 41, 289. |